Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8c0521756ce6c2ca196bb6e3cbb928e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B6-2552 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C03B37-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-359 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03B37-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01J3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-3577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01J3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03B37-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-359 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03B37-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-487 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03B13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-17 |
filingDate |
2021-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c58818ccff69abda2a7c841b4b9c8f9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a89c7cdc0ed9be9780562edb8346b837 |
publicationDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021156868-A1 |
titleOfInvention |
Cell characterization using near-infrared spectroscopy |
abstract |
An in-vitro method of detecting the effect of one or more compound (s) on cells, comprising the steps of: transmitting near-infrared light through a tapered silica optical fiber immersed in a sample of cells treated with the compound (s); obtaining spectroscopic data across at least a portion of the wavelength range of 700 nm to 1800 nm, wherein the spectroscopic data includes one or more spectral markers indicative of the action of said compound (s) on the cells. Method of treatment of cancer patients and a device for examining the cells by NIR spectroscopy are also included. |
priorityDate |
2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |